Research on Nar-e-Farsi in Unani Medicine.

Efficacy of Nuqoo-e-Ushba and topical application of Tila of Tukhm-e-Alsi, Tukhm-e-Tarah Tezak, Khardal and Sirka in Nar-e-Farsi Muzmin (Chronic Eczema) - A Self-Controlled Study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060955

Enrollment

Registered

2023-12-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: Orally Nuqoo-e-Ushba and topically tila of Tukhme Alsi, Tukhme Tarah Tezak, Khardal and sirka.: Ushba 10gms soaked in 30ml water at night and nuqoo is prepared in the morning. Orally 10

Eligibility

Inclusion criteria

Inclusion criteria: Patients of all genders with age group between 18-50 years. Diagnosis will be made on the basis of Hanifin and Rajka Criteria. Eczema of mild to moderate in severity. Patients who have agreed to sign the informed consent form and follow up during the protocol.

Exclusion criteria

Exclusion criteria: Patient below 18 and above 50 years of age. Patients with DM, HTN, Autoimmune and other skin diseases. Eczema due to secondary infections. Pregnant and lactating women. Patient not willing to attend treatment schedule regularly.

Design outcomes

Primary

Measure	Time frame
Decrease in Eczema Area and Severity Index (EASI) Score. Change in photographs of the lesion.Timepoint: Baseline, 10th day, 20th day and 30th day	—

Secondary

Measure	Time frame
Decrease in Patient-Oriented Eczema Measures (POEM) Questionnaire.Timepoint: Baseline, 10th day, 20th day & 30th day	—

Countries

India

Contacts

Public ContactDr Sadiya Sarwath

Government Unani Medical College and Hospital

ayesharafeeq81@gmail.com9035158024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026